These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 2999972)
1. The immune system in AIDS. Laurence J Sci Am; 1985 Dec; 253(6):84-93. PubMed ID: 2999972 [TBL] [Abstract][Full Text] [Related]
2. Immunopathogenesis of the acquired immunodeficiency syndrome. Bowen DL; Lane HC; Fauci AS Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403 [TBL] [Abstract][Full Text] [Related]
3. Immunologic abnormalities in the acquired immunodeficiency syndrome. Lane HC; Fauci AS Annu Rev Immunol; 1985; 3():477-500. PubMed ID: 2415141 [TBL] [Abstract][Full Text] [Related]
4. Implications of the discovery of HTLV-III for the treatment of AIDS. Yarchoan R; Mitsuya H; Matsushita S; Broder S Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113 [TBL] [Abstract][Full Text] [Related]
5. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus. McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638 [TBL] [Abstract][Full Text] [Related]
6. Animal models for HIV infection and AIDS: memorandum from a WHO meeting. Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118 [TBL] [Abstract][Full Text] [Related]
7. Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome. Dorsett B; Cronin W; Chuma V; Ioachim HL Am J Med; 1985 Apr; 78(4):621-6. PubMed ID: 2984932 [TBL] [Abstract][Full Text] [Related]
8. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)]. Zielinski C Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs. Kloster BE; Tomar RH; Stockman JA; Lamberson HV; Merl SA; John PA; Groth DM; Poiesz BJ Am J Clin Pathol; 1985 Apr; 83(4):450-6. PubMed ID: 2984918 [TBL] [Abstract][Full Text] [Related]
10. The prospects for and pathways toward a vaccine for AIDS. Francis DP; Petricciani JC N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596 [TBL] [Abstract][Full Text] [Related]
12. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus. Hoxie JA; Haggarty BS; Rackowski JL; Pillsbury N; Levy JA Science; 1985 Sep; 229(4720):1400-2. PubMed ID: 2994222 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Walker BD; Flexner C; Paradis TJ; Fuller TC; Hirsch MS; Schooley RT; Moss B Science; 1988 Apr; 240(4848):64-6. PubMed ID: 2451288 [TBL] [Abstract][Full Text] [Related]
14. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
15. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Fahey JL; Prince H; Weaver M; Groopman J; Visscher B; Schwartz K; Detels R Am J Med; 1984 Jan; 76(1):95-100. PubMed ID: 6229182 [TBL] [Abstract][Full Text] [Related]
16. Virologic, immunologic, and epidemiologic associations with AIDS among gay males in a low incidence area. Rinaldo C; Lyter D; Kingsley L; DeBiasio R; Zhao JQ; Lin T; Jensen F; Atchison R; Zerbe A; Rabin B Ann N Y Acad Sci; 1984; 437():544-8. PubMed ID: 6100008 [No Abstract] [Full Text] [Related]
17. Possible viral interactions in the acquired immunodeficiency syndrome (AIDS). Hirsch MS; Schooley RT; Ho DD; Kaplan JC Rev Infect Dis; 1984; 6(5):726-31. PubMed ID: 6095405 [TBL] [Abstract][Full Text] [Related]
18. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model. Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
20. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]